Here is the latest, from Yahoo! Biz reporting:
. . .Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, today announced the completion of its acquisition of the aqua business of Elanco Animal Health Incorporated. The completion of this acquisition bolsters Merck Animal Health’s position in the aqua industry with a comprehensive approach to promote fish health, welfare and sustainability in aquaculture, conservation, and fisheries. . . .
As a result of the acquisition, Merck Animal Health now owns innovative products such as CLYNAV®, a new generation DNA-based vaccine that protects Atlantic salmon against pancreas disease and IMVIXA®, an anti-parasitic sea lice treatment and water treatment products for warm water production, complementing Merck Animal Health’s vaccine portfolio. . . .
Now you know -- smile. [Just for fun, here is some deep 2014 history, on the Elanco name, when Lilly owned its cattle fattener asset, called Optaflexx® (and Merck's Zilmax® hit a deeply unfortunate ditch in the road) -- all courtesy of yours truly. Grin.]
And Ariane 6 is safely in orbit. Well done, ESA! Onward.
नमस्ते
No comments:
Post a Comment